Profile data is unavailable for this security.
About the company
Oncimmune Holdings plc is a United Kingdom-based immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. The Company's principal activity is the development and commercialization of technologies that enable cancer diagnosis. Its service offerings include ImmunoINSIGHTS. The ImmunoINSIGHTS service business leverages its technology platform and methodologies across multiple diseases, to offer life-science organizations actionable insights for therapies across the development and product lifecycle. Its immune-profiling technology helps the Company in identifying trial participants and patients into clinically relevant subgroups, which enables the development of targeted treatments. The Company's subsidiaries include Oncimmune Americas LLC, Oncimmune Germany GmbH, and Oncimmune LLC, among others.
- Revenue in GBP (TTM)1.15m
- Net income in GBP-6.15m
- Incorporated2015
- Employees56.00
- LocationOncimmune Holdings PLC1 Park RowLEEDS LS1 5ABUnited KingdomGBR
- Phone+44 11 5823 1869Fax+44 11 5823 1958
- Websitehttps://www.oncimmune.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Chill Brands Group PLC | 146.62k | -3.64m |
Kanabo Group PLC | 813.00k | -4.66m |
Abingdon Health PLC | 5.34m | -2.24m |
Synairgen plc | 0.00 | -9.99m |
Shield Therapeutics PLC | 7.21m | -46.89m |
Incanthera PLC | 0.00 | -1.48m |
Genincode PLC | 1.72m | -6.73m |
Provexis plc | 598.08k | -496.59k |
LungLife AI Inc | 36.71k | -4.32m |
Destiny Pharma PLC | 0.00 | -5.66m |
Verici DX PLC | 15.16k | -8.95m |
OptiBiotix Health PLC | 689.10k | -13.17m |
Oncimmune Holdings PLC | 1.15m | -6.15m |
Skinbiotherapeutics PLC | 161.65k | -2.88m |
Hemogenyx Pharmaceuticals PLC | 0.00 | -6.69m |
Oxford Biodynamics PLC | 510.00k | -10.83m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Hargreaves Lansdown Asset Management Ltd.as of 31 Aug 2023 | 3.14m | 4.23% |
Chelverton Asset Management Ltd.as of 31 Aug 2023 | 3.01m | 4.06% |
Unicorn Asset Management Ltd.as of 31 Mar 2024 | 1.16m | 1.57% |
Gabelli Funds LLCas of 29 Dec 2023 | 2.90k | 0.00% |